Search
SOLACI Congress
HomeCONGRESSInternational Congresses

International Congresses

View Category
Day 3

After 80: The octogenarian patients with acute coronary syndrome benefit from an aggressive strategy

This work published simultaneously in The New England Journal of Medicine showed that patients over eighty years...
solaci -
Learn More
Day 3

Mitral valve repair in moderate ischemic mitral regurgitation

Article Up to 50% of acute myocardial infarctions are associated to mitral regurgitation of some degree and 10%...
solaci -
Learn More
Day 3

INHERIT: Losartan in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is the most common hereditary cardiac pathology (1/1500) and is associated to heart failure, angina,...
solaci -
Learn More
Day 3

Reducing antibiotic prophylaxis: impact on endocarditis incidence.

Antibiotic prophylaxis before dental procedures has been the gold standard in preventing infective endocarditis, despite the lack...
solaci -
Learn More
Day 3

Atenolol vs. Losartan in children and young adults with Marfan syndrome

Article Aortic root dissection is the main cause of mortality in Marfan syndrome. Recent studies suggest that losartan...
solaci -
Learn More
Day 4

LIFELINE STEMI ACCELERATOR TRIAL: Improving the duration of treatment of AMI can save even more lives

Matthew W Sherwood2014-11-20
solaci -
Learn More
Day 4

AVOID: Randomized controlled trial of oxygen therapy in AMI with ST-segment elevation: Air versus oxygen in myocardial infarction

Dion Stub2014-11-20
solaci -
Learn More
Day 4

EVOLVE II TRIAL: SYNERGY everolimus-eluting stent is not inferior to Promus Element

Dean J. Kereiakes2014-11-20
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy